Patents
Sitemap › A61 - Medical or veterinary science; Hygiene › A61P - Specific therapeutic activity of chemical compounds or medicinal preparations › A61P 43 - Drugs for specific purposes, not provided for in groups
Patents for A61P 43 - Drugs for specific purposes, not provided for in groups (156,317)
08/2000
08/08/2000US6100037 Polynucleotide encoding a cyclic nucleotide phosphodiesterase having a specific amino acid sequence; diagnosis, treatment, and prevention of cancer and immune disorders; anticarcinogenic/antidiabetic/antiarthritic agents
08/08/2000US6099863 Spray drying mixture
08/08/2000US6099854 Dry composition containing flavonol useful as a food supplement
08/08/2000US6099845 Process for the preparation of Rhus verniciflua extract and anti-cancer composition containing same
08/08/2000US6099567 Stomach submucosa derived tissue graft
08/08/2000US6099532 Disposable monomer dispenser and vial breaker
08/08/2000CA2233144C Arf-p19, a novel regulator of the mammalian cell cycle
08/08/2000CA2216165C Ndf peptides
08/08/2000CA2188227C Combination antiemetic therapy using nk-1 receptor antagonists
08/08/2000CA2177743C New alkoxy-aryl compounds, process for preparing the same and pharmaceutical compositions containing them
08/08/2000CA2138270C Prosthetic devices having enhanced osteogenic properties
08/08/2000CA2087341C Bone growth stimulator
08/08/2000CA2027041C Aroyl-ureas
08/08/2000CA2018438C Imidazolyl-alkenoic acids
08/08/2000CA2010009C Tricyclic fused pyrimidine derivatives, their production and use
08/08/2000CA1341082C Method of treating tumor cells by inhibiting growth factor receptor function
08/03/2000WO2000045177A1 Assays for modulators of elongation factor p activity
08/03/2000WO2000044908A2 Comp/tsp-1, comp/tsp-2 and other tsp chimeric proteins
08/03/2000WO2000044903A1 Platelet-derived growth factor/vascular endothelial growth factor-like growth factor h, and uses thereof
08/03/2000WO2000044901A1 Transcriptional regulation of the human beta3-adrenergic receptor gene
08/03/2000WO2000044900A2 Nucleic-acid binding proteins
08/03/2000WO2000044785A1 Gcsf conjugates
08/03/2000WO2000044777A1 Antibodies specific to kdr and uses thereof
08/03/2000WO2000044774A2 Inhibition of stat3 signal transduction for human cancer therapy
08/03/2000WO2000044756A1 Thiazolopyrimidine compounds, process for the preparation of the same and uses thereof
08/03/2000WO2000044753A1 Pirazino(aza)indole derivatives
08/03/2000WO2000044751A1 4-OXO-3,5-DIHYDRO-4H-PYRIDAZINO[4,5-b]INDOLE-1-CARBOXAMIDE DERIVATIVES, PREPARATION AND THERAPEUTIC USE
08/03/2000WO2000044750A1 PURINE INHIBITORS OF CYCLIN DEPENDENT KINASE 2 AND Iλ-A$g(a)
08/03/2000WO2000044749A1 Acetylenic ortho-sulfonamido and phosphinic acid amido bicyclic heteroaryl hydroxamic acids as tace inhibitors
08/03/2000WO2000044745A1 Carbamate derivatives of diaryl 1,3,4-oxadiazolone
08/03/2000WO2000044743A1 Amide derivatives and drug compositions
08/03/2000WO2000044740A2 Heteroaryl acetylenic sulfonamide and phosphinic acid amide hydroxamic acid tace inhibitors
08/03/2000WO2000044739A1 Reverse hydroxamate inhibitors of matrix metalloproteinases
08/03/2000WO2000044730A1 2,3,4,5-tetrahydro-1h-[1,4]benzodiazepine-3-hydroxamic acid as matrix metalloproteinase inhibitors
08/03/2000WO2000044728A1 Substituted bicyclic derivatives useful as anticancer agents
08/03/2000WO2000044721A1 3,7-disubstituted indole derivatives and medicinal compositions containing the same
08/03/2000WO2000044716A1 Acetylenic sulfonamide thiol tace inhibitors
08/03/2000WO2000044713A1 Alkynyl containing hydroxamic acid compounds as tace inhibitors
08/03/2000WO2000044711A1 ACETYLENIC $G(b)-SULFONAMIDO AND PHOSPHINIC ACID AMIDE HYDROXAMIC ACID TACE INHIBITORS
08/03/2000WO2000044710A2 Acetylenic aryl sulfonamide and phosphinic acid amide hydroxamic acid tace inhibitors
08/03/2000WO2000044709A2 ACETYLENIC α-AMINO ACID-BASED SULFONAMIDE HYDROXAMIC ACID TACE INHIBITORS
08/03/2000WO2000044438A1 Delivery of macromolecules into cells
08/03/2000WO2000044409A1 Formulations comprising antisense nucleotides to connexins
08/03/2000WO2000044404A2 Methods for inhibiting brain tumor growth by using selected integrin antagonists
08/03/2000WO2000044401A1 Use of a melanoma inhibiting activity factor (mia) for cartilage and bone repair
08/03/2000WO2000044400A1 Treatment for diabetes
08/03/2000WO2000044384A1 USE OF PYRIDAZINO[4,5-b]INDOLE-1-ACETAMIDE DERIVATIVES FOR PREPARING MEDICINES FOR TREATING DISEASES RELATED TO THE DYSFUNCTION OF PERIPHERAL BENZODIAZEPIN RECEPTORS
08/03/2000WO2000044382A1 Composition and method for treating diabetes
08/03/2000WO2000044374A1 Use of anticonvulsant derivatives for treating bulimia nervosa
08/03/2000WO2000044371A1 2-adamantanemethanamine compounds for treating abnormalities in glutamatergic transmission
08/03/2000WO2000044364A2 P53 inhibitors and their use for the treatment of cancer, hyperthermia, hypoxia, a burn, trauma to the central nervous system, a seizure, acute inflammation, tissue ageing, preservation of organs for transplant and preparation of a host for bone marrow transplant
08/03/2000WO2000044362A2 The use of 4-h-1-benzopyran-4-one derivatives as inhibitors of smooth muscle cell proliferation
08/03/2000WO2000044361A2 Highly purified ethyl epa and other epa derivatives for psychiatric and neurological disorders
08/03/2000WO2000044356A1 Hydrogel compositions useful for the sustained release of macromolecules and methods of making same
08/03/2000WO2000044354A1 Lyophilisates with improved reconstitutibility
08/03/2000WO2000044350A1 Transnasal transport/immunisation with highly adaptable carriers
08/03/2000WO2000032175A3 METHODS AND COMPOSITIONS FOR RESTORING CONFORMATIONAL STABILITY OF A PROTEIN OF THE p53 FAMILY
08/03/2000WO2000028061A3 Adeno-associated virus serotype 1 nucleic acid sequences, vectors and host cells containing same
08/03/2000WO2000027874A3 Nucleic acids encoding transferrin receptor-like proteins and products related thereto
08/03/2000WO2000027850A3 Crf receptor antagonists and methods relating thereto
08/03/2000WO2000024412A3 Use of vegf-c or vegf-d gene or protein to prevent restenosis
08/03/2000WO2000023471A3 Use of a cytokine-producing lactococcus strain to treat colitis
08/03/2000WO2000021926A3 6-SUBSTITUTED PYRAZOLO[3,4-d]PYRIMIDIN-4-ONES USEFUL AS CYCLIN DEPENDENT KINASE INHIBITORS
08/03/2000WO2000020421A3 TRICYCLIC Δ3-PIPERIDINES AS α2-ANTAGONISTS
08/03/2000WO2000017346A3 Hairpin hybridizer molecules for modulation of gene expression
08/03/2000WO2000008006A3 Piperidine and piperazine derivatives, process for their preparation and pharmaceutical compounds containing them
08/03/2000WO2000006589A9 Prostate derived ets factor
08/03/2000WO1999062561A3 Gene therapy method
08/03/2000WO1999026942A8 5-(2-imidazolinylamino)-benzimidazole derivatives, their preparation and their use as .alpha.-adrenoceptor agonists with improved metabolic stability
08/03/2000DE19903275A1 Lyophilisate mit verbesserter Rekonstituierbarkeit Lyophilisates with improved reconstitutability
08/03/2000DE19901921A1 Polymorphe von Telmisartan, Verfahren zu deren Herstellung und deren Verwendung zur Herstellung eines Arzneimittels Polymorphs of telmisartan, to processes for their preparation and their use for the preparation of a medicament
08/03/2000CA2730386A1 Formulations comprising antisense nucleotides to connexins
08/03/2000CA2361621A1 Inhibition of stat3 signal transduction for human cancer therapy
08/03/2000CA2361553A1 Antibodies specific to kdr and uses thereof
08/03/2000CA2361518A1 Purine inhibitors of cyclin dependent kinase 2 and ikb-.alpha.
08/03/2000CA2360687A1 Composition and method for treating diabetes
08/03/2000CA2360674A1 2-adamantanemethanamine compounds for treating abnormalities in glutamatergic transmission
08/03/2000CA2360671A1 P53 inhibitors and therapeutic use of the same
08/03/2000CA2360643A1 Transnasal transport/immunisation with highly adaptable carriers
08/03/2000CA2360374A1 Comp/tsp-1, comp/tsp-2 and other tsp chimeric proteins
08/03/2000CA2360146A1 Methods for inhibiting brain tumor growth by using selected integrin antagonists
08/03/2000CA2360064A1 Transcriptional regulation of the human beta3-adrenergic receptor gene
08/03/2000CA2359701A1 Nucleic-acid binding proteins
08/03/2000CA2359034A1 Pyrazino(aza)indole derivatives
08/03/2000CA2359011A1 Thiazolopyrimidine compound, its production and use
08/03/2000CA2358964A1 Carbamate derivatives of diaryl 1,3,4-oxadiazolone
08/03/2000CA2356855A1 Acetylenic aryl sulfonamide and phosphinic acid amide hydroxamic acid tace inhibitors
08/03/2000CA2356481A1 Heteroaryl acetylenic sulfonamide and phosphinic acid amide hydroxamic acid tace inhibitors
08/03/2000CA2356480A1 Acetylenic sulfonamide thiol tace inhibitors
08/03/2000CA2356346A1 Alkynyl containing hydroxamic acid compounds as tace inhibitors
08/03/2000CA2356345A1 Acetylenic beta-sulfonamido and phosphinic acid amide hydroxamic acid tace inhibitors
08/03/2000CA2356313A1 Alkynyl containing hydroxamic acid derivatives, their preparation and their use as matrix metalloproteinase (mmp) inhibitors/tnf-alpha converting enzyme (tace) inhibitors
08/03/2000CA2356299A1 Acetylenic .alpha.-amino acid-based sulfonamide hydroxamic acid tace inhibitors
08/03/2000CA2356267A1 2,3,4,5-tetrahydro-1h-¬1,4|benzodiazepine-3-hydroxamic acid as matrix metalloproteinase inhibitors
08/03/2000CA2355735A1 Acetylenic ortho-sulfonamido and phosphinic acid amido bicyclic heteroaryl hydroxamic acids as tace inhibitors
08/03/2000CA2326741A1 The use of gastrin in the treatment of diabetes
08/02/2000EP1024198A2 Pseudo-adenoviral vectors for the gene therapy of haemophiliae
08/02/2000EP1024134A1 Aminobutanoic acid derivatives
08/02/2000EP1023903A1 Use of life attenuated bacteria for the manufacture of a submucosal vaccine
08/02/2000EP1023902A1 Pharmaceutical preparation for the treatment of inflammatory processes
1 ... 1138 1139 1140 1141 1142 1143 1144 1145 1146 1147 1148 1149 1150 1151 1152 1153 1154 1155 1156 1157 1158 ... 1564